Pain Oral-Intranasal Fentanyl (Abstral, Actiq, Fentora, Lazanda, Onsolis, Subsys)
|
|
|
- Daniel Simmons
- 5 years ago
- Views:
Transcription
1 Pennsylvania Employees Benefit Trust Fund (PEBTF) and n- Medicare Eligible Retired Employees Health Program (REHP), Step Therapy and Quantity Limit List Your doctor needs to get prior authorization for the drugs listed below before your prescription benefit plan administered by CVS Caremark will cover them. The prior authorization process ensures that you are receiving the appropriate drugs for the treatment of specific conditions and in quantities approved by the U.S. Food and Drug Administration (FDA). For prior authorization review, your doctor should call CVS Caremark toll-free at before you go to the pharmacy. The prior authorization line is for your doctor s use only. Acne (PA required age 20+) Topical Retinoids (Atralin, Avita, Retin-A, Retin-A Micro, Tretin-X, tretinoin) ADHD/Narcolepsy (PA required age 20+) Amphetamine products (Adderall, Adderall XR, Desoxyn, Dexedrine, LiQuadd/ProCentra, Vyvanse) Methylphenidate products (Concerta, Daytrana, Focalin/XR, Metadate-all, Methylin-all, Quillivant XR, Ritalin-all), Strattera (atomoxetine) Anti-fungals Penlac (ciclopirox) Pain Oral-Intranasal Fentanyl (Abstral, Actiq, Fentora, Lazanda, Onsolis, Subsys) Miscellaneous Regranex (becaplermin) Arava (leflunomide) Specialty Guideline Management for Specialty Drugs Your doctor needs to get prior authorization for specialty drugs before they will be covered by your prescription benefit plan. The prior authorization process ensures that you are receiving the appropriate drugs for the treatment of specific conditions. For a full list of specialty drugs, refer to For specialty drug prior authorization review, your doctor should call CVS Caremark tollfree at before you go to the pharmacy. The prior authorization line is for your doctor s use only. Listed products are for informational purposes only and are not intended to replace the clinical judgment of the prescriber. Due to the large number of available medicines, this list may not be all inclusive and may change without notice. Dispensing limits and/or prior authorization requirements apply to all brand and generic equivalents unless otherwise indicated. Products distributed and therapies covered by CVS Caremark may change or expand from time to time. This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. Your privacy is important to us. Our employees are trained regarding the appropriate way to handle your private health information. TDD:
2 Step Therapy You are required to try another drug before your prescription benefit plan will cover one of the drugs listed below. Please consult with your doctor about what covered medications are right for you. Your doctor should call CVS Caremark toll-free at to request prior authorization. The prior authorization line is for your doctor s use only. Anti-diabetes must have other diabetic therapy in claims history Bydureon (exenatide extended release) Byetta (exenatide) Victoza (liraglutide) Brand Angiotensin II Blockers (ARBs) and Direct Renin Inhibitors try a generic first Atacand/Atacand HCT (also subject to formulary coverage) Benicar/Benicar HCT Diovan/Diovan HCT Edarbi/Edarbyclor (also subject to formulary coverage) Micardis/Micardis HCT Tekturna/Tekturna HCT Teveten HCT (also subject to formulary coverage) COX-2 Inhibitors Celebrex (celecoxib) Sedative Hypnotics try a generic first Edluar (zolpidem sublingual tablet) Intermezzo (zolpidem sublingual tablet) - also subject to formulary coverage Zolpimist (zolpidem oral spray) The drugs listed on the following pages have limits based on U.S. Food and Drug Administration (FDA)-approved prescribing information, approved medical guidelines and/or the average utilization quantity for the drugs. The limits listed below affect only the amount of medication that the prescription benefit plan pays for, not whether you can get a greater quantity. The final decision about the amount of medication you receive remains between you and your doctor. te: Some of the quantity limits have a prior authorization available if you exceed the drug s limit. Those drugs with a prior authorization available are noted in chart on the following pages. If your doctor has determined that a greater amount is appropriate, your doctor should call CVS Caremark toll-free at to request prior authorization for a larger quantity. The prior authorization line is for your doctor s use only.
3 30-day 90-day Anti-Migraine (quantities accumulate across the class) Alsuma Injection (sumatriptan) 10 units (5 ml) 30 units (15 ml) Yes Amerge (naratriptan) 9 tablets 27 tablets Yes Axert (almotriptan) 12 tablets 36 tablets Yes Frova (frovatriptan) 9 tablets 27 tablets Yes Imitrex (sumatriptan) 4 mg Injection 8 units (4 ml) 24 units (12 ml) Yes Cartridges, Syringes, Vials Imitrex (sumatriptan) 6 mg Injection Cartridges, Syringes, Vials 10 units (5 ml) 30 units (15 ml) Yes Imitrex (sumatriptan) nasal spray (NS) 12 nasal units 36 nasal units Yes Imitrex (sumatriptan) oral 9 tablets 27 tablets Yes Maxalt, Maxalt MLT (rizatriptan) 12 tablets 36 tablets Yes Migranal (dihydroergotamine nasal 8 nasal units 24 nasal units spray) Relpax (eletriptan) 12 tablets 36 tablets Yes Sumavel DosePro (sumatriptan) 12 DosePro units 36 DosePro units Yes Treximet (sumatriptan/naproxen 9 tablets 27 tablets Yes sodium) Zomig nasal spray (zolmitriptan) 12 nasal units 36 nasal units Yes Zomig Zomig ZMT (zolmitriptan) 12 tablets 36 tablets Yes Influenza Relenza Caps (zanamivir inhalation) 40 capsules per 180 days Yes Tamiflu 30 mg Caps (oseltamivir) 28 capsules per 180 days Yes Tamiflu 45 mg, 75 mg Caps (oseltamivir) 14 capsules per 180 days Yes Tamiflu 60 mg/5 ml, 30 mg/5 ml Oral Liquid (oseltamivir) 180 ml per 180 days Yes Pain butorphanol (Stadol NS) 2 bottles 6 bottles Yes Sedative/hypnotics (quantities accumulate across the class) Benzodiazepines Doral (quazepam) 15 tablets 45 tablets Yes estazolam (Prosom) 15 tablets 45 tablets Yes flurazepam (Dalmane) 15 capsules 45 capsules Yes temazepam (Restoril, Strazepam) 15 capsules 45 capsules Yes triazolam (Halcion) 10 tablets 30 tablets Yes
4 30-day 90-day n-benzodiazepines Lunesta (eszopiclone) 15 tablets 45 tablets Yes Rozerem (ramelteon) 15 tablets 45 tablets Yes zaleplon (Sonata) 15 capsules 45 capsules Yes zolpidem (Ambien/Ambien CR) 15 tablets 45 tablets Yes Respiratory - Beta 2 Agonist/Combinations Advair Diskus (fluticasone/salmeterol) 1 container (60 ea) 3 containers (180 ea) Advair HFA (fluticasone/salmeterol) 1 container (12 g) 3 containers (36 g) Albuterol inhalation solution (AccuNeb) 0.63 mg/3 ml and 1.25 mg/3 ml 125 vials (375 ml) 375 vials (1125 ml) Albuterol inhalation solution 0.083% 125 vials (375 ml) 375 vials (1125 ml) Albuterol inhalation solution 0.5% 3 (20 ml) containers 9 (20 ml) containers Arcapta Neohaler (indacaterol) 1 container (30 ea) 3 containers (90 ea) Brovana inhalation solution (aformeterol tartrate) 60 vials (120 ml) 180 vials (360 ml) Dulera Inhalation Aerosol 100 mcg/5 mcg and 200 mcg/5 mcg (mometasone/ 1 container (13 gm) 3 containers (39 gm) formoterol) Foradil Aerolizer (formoterol) 1 container (60ea) 3 containers (180 ea) Maxair Autohaler (pirbuterol) 1 container (14 gm) 3 containers (42 gm) Perforomist inhalation solution (formoterol) 60 vials (120 ml) 180 vials (360 ml) 2 containers, varies 6 containers, varies by ProAir HFA inhaler (albuterol) by package size package size 2 containers, varies 6 containers, varies by Proventil HFA inhaler (albuterol) by package size package size Serevent Diskus (salmeterol) 1 container (60 ea) 3 containers (180 ea) Symbicort inhalation aerosol (budesonide/ formoterol) 1 container (11 gm) 3 containers (31 gm) 2 containers, varies 6 containers, varies by Ventolin HFA inhaler (albuterol) by package size package size Xopenex HFA inhaler (levalbuterol) 2 containers (30 gm) 6 containers (90 gm) Xopenex inhalation solution 0.31 mg/3 ml (levalbuterol) 96 vials (288 ml) 288 vials (864 ml) Xopenex inhalation solution 0.63 mg/3 ml (levalbuterol) 96 vials (288 ml) 288 vials (864 ml) Xopenex inhalation solution 1.25 mg/3 ml (levalbuterol) 96 vials (288 ml) 288 vials (864 ml) Xopenex inhalation soln conc 1.25 mg/0.5 ml (levalbuterol) 90 vials (90 ea) 270 vials (270 ea)
5 30-day 90-day Respiratory - Mast Cell Stabilizers and Anticholinergics Atrovent HFA Inhaler (ipratropium 2 containers bromide) (26 gm) 6 containers (78 gm) Combivent Respimat Inhaler (ipratropium/albuterol) 2 containers (8 gm) 6 containers (24 gm) Cromolyn Inhalation Solution (cromolyn) 120 units (240 ml) 360 units (720 ml) DuoNeb Inhalation Solution (ipratropium/albuterol) 180 vials (540 ml) 540 vials(1620 ml) Ipratropium Inhalation Solution (ipratropium bromide) 125 units (313 ml) 375 units (939 ml) Spiriva Handihaler (tiotropium) 30 units + 90 units + 1 Handihaler device 1 Handihaler device Tudorza Pressair Inhaler (aclidinium bromide) 1 container 3 containers Respiratory - Inhaled Corticosteroids Alvesco inhalation (ciclesonide) Asmanex 110 mcg (mometasone furoate) Asmanex 30 Aer 220 mcg (mometasone furoate) 4 containers 12 containers Asmanex 60 Aer 220 mcg (mometasone furoate) 2 packages 6 packages Asmanex 120 Aer 220 mcg (mometasone furoate) 1 package 3 packages Flovent Diskus 50 mcg & 100 mcg/inhalation (fluticasone) 2 packages 6 packages Flovent Diskus 250 mcg/inhalation (fluticasone) 4 packages 12 packages Flovent HFA 44 & 110 mcg/inhalation (fluticasone) 1 inhaler 3 inhalers Flovent HFA 220 mcg/inhalation (fluticasone) Pulmicort Flexhaler 180 mcg/inhalation (budesonide) Pulmicort Flexhaler 90 mcg/inhalation (budesonide) Pulmicort Respules 0.25 mg or 0.5 mg per respule (budesonide) 60 respules 180 respules
6 30-day 90-day Pulmicort Respules 1 mg per respule (budesonide) 30 respules 90 respules Qvar Inhaler 40 mcg (beclomethasone) 1 container 3 containers Qvar Inhaler 80 mcg (beclomethasone) Allergy - Intranasal Steroids/Antihistamines Astelin (azelastine) Astepro (azelastine) Beconase AQ (beclomethasone) Dymista (azelastine/fluticasone) 1 container 3 containers Flonase (fluticasone) 1 container 3 containers Flunisolide (flunisolide) Nasacort AQ (triamcinolone) 1 container 3 containers Nasonex (mometasone) Omnaris (ciclesonide) 1 container 3 containers Patanase (olopatadine) 1 container 3 containers Qnasl (beclomethasone) 1 container 3 containers Rhinocort Aqua (budesonide) Veramyst (fluticasone furoate) 1 container 3 containers Zetonna (ciclesonide) 1 container 3 containers Log in to to check coverage and copay* information for a specific medicine. For additional information, contact a CVS Caremark Customer Care Representative toll-free at *Copay, copayment or coinsurance means the amount a plan member is required to pay for a prescription in accordance with a Plan, which may be a deductible, a percentage of the prescription price, a fixed amount or other charge, with the balance, if any, paid by a Plan.
University System of Georgia Prior Authorization, Step Therapy and Quantity Limit List (Updated 1/1/2016)
University System of Georgia, Step Therapy and Quantity Limit List (Updated 1/1/2016) (PA) Your doctor will need to obtain a prior authorization for the drugs listed below, before your prescription drug
Diabetes Fortamet (metformin ER), Glumetza (metformin ER) generic of Glucophage XR (metformin ER) preferred
Pennsylvania Employees Benefit Trust Fund (PEBTF) and n-medicare Eligible Retired Employees Health Program (REHP), Step Therapy and Quantity Limit List Your doctor needs to get prior authorization for
Quantity Management. October 2017
Quantity Management October 2017 What Is Quantity Management? It s a quality and safety program that promotes the safe use of medications. The program limits the amount of some medications we cover. We
Data Class: Internal. 1 inhaler (30 blisters OR 14 blisters institutional pack) per presciption
To help make the use of prescription drugs safer and more affordable, our plan is now using a Drug Quantity Management program. That is, for certain medications, you can receive an amount to last you a
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
Pequot Health Care Smart Quantity Program*
Pequot Health Care 1 Annie George Drive Mashantucket, CT 06338 Phone: 1-888-779-6638 Fax: 1-860-396-6494 Pequot Health Care Smart Quantity Program* Updated January 2018 *Quantity Program limits apply to
Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.
Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. AccuNeb inhalation 0.021% solution: 0.63mg/3mL 3-4 times solution
Step Therapy Medications
Step Therapy Medications Step Therapy (ST PA ) is an automated form of prior authorization. It encourages the use of therapies that should be tried first, before other treatments are covered, based on
Management. Quantity. What Is Quantity Management? What Happens at the Pharmacy? Which Medications Are Included? January 2016
January 2016 Quantity Management What Is Quantity Management? It s a quality and safety program that promotes the safe use of medications. The program limits the amount of some medications that we cover.
Management. Quantity. What Is Quantity Management? What Happens at the Pharmacy? Which Medications Are Included? January 2017
Quantity January 2017 Management What Is Quantity Management? It s a quality and safety program that promotes the safe use of medications. The program limits the amount of some medications that we cover.
Select Inhaled Respiratory Agents
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
A Visual Approach to Simplifying Respiratory Drug Regimens
A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP 3 Main Categories Inhaled Respiratory Drugs Binds to beta-2 receptors Relaxation of smooth muscles in the lung
A Visual Approach to Simplifying Respiratory Drug Regimens
A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP October 23, 2017 Learning Objectives Be able to list at least 3 major adverse effects of inhaled medications
A Visual Approach to Simplifying Respiratory Drug Regimens
Adverse Effects of Inhaled Medications A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP June 28, 2017 Drug Category Beta 2 agonists antagonists Adverse Effects
AIRDUO RESPICLICK (fluticasone-salmeterol) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol
DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida
First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida Prasad Peri, Ph.D., Branch Chief, ONDQA, FDA March 19, 2014 1 Topics for discussion Introduction
Diagnosis and Management of Asthma
Supporting Evidence: Diagnosis and Management of Asthma The subdivision of this section is: Appendix B Tables Copyright 2016 by 1 Eleventh Edition/December 2016 Appendix B Asthma Summary Tables Class:
Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS
Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS Objectives Categorize the new asthma and COPD inhalers in to existing or newly created categories Discuss the
REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE
REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE ID NUMBER: 0a) Date of Collection / / 0b) Staff Code Instructions: This form should be completed during the participant s clinic visit. 1) Are you regularly
1, 2014 PHARMACY BENEFIT
Effective 01/01/2007City of Plano Employee Benefit Design Summary Effective Date: January 1, 2014 PHARMACY BENEFIT CVS/CAREMARK TOLLFREE: 888-850-8245 ID CARD & NETWORK PHARMACIES: Identification Card
Secretary for Health and Family Services Selections for Preferred Products
Secretary for Health and Family Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Secretary for Health and Family Services based
Commissioner for the Department for Medicaid Services Selections for Preferred Products
Commissioner for the Department for Medicaid Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Commissioner for the Department for
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Seebri Neohaler) Reference Number: CP.CPA.150 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy
South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina
South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina 29202-8206 Pharmacy and Therapeutics (P&T) Committee Meeting MINUTES 1. Call To Order A meeting of the
2014 Quantity Limits (QL) Criteria
2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food
OHIO MEDICAID PHARMACY COVERAGE
OHIO MEDICAID PHARMACY COVERAGE This information is intended for use by providers to help select the most appropriate cost-effective medication and formulation for their patients. Prescribers should utilize
The Medical Letter. on Drugs and Therapeutics
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
Responsible Quantity Program Effective 4/1/10. Abilify oral solution
Abilify Abilify Discmelt Abilify oral solution Aciphex Actiq Page 1 of 9 750 ml 120 units Actonel 5 mg, 30 mg Actonel 35 mg 4 tabs Actonel 75 mg 2 tabs Actonel 150 mg 1 tab Actonel with Calcium Adcirca
Drug Class Monograph
Drug Class Monograph Class: Inhaled Corticosteroids Drugs: Aerospan (flunisolide), Advair Diskus, Advair HFA (fluticasone/salmeterol), Alvesco (ciclesonide), Arnuity Ellipta (fluticasone furoate), Asmanex
Avoid paying too much for your prescriptions
Quality health plans & benefits Healthier living Financial well-being Intelligent solutions 2017 Aetna Rx Step Program Medicine List Avoid paying too much for your prescriptions It s important to try to
Pharmacy Updates Summary
All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 4/16/2014 Effective date: 5/15/2014 Therapeutic Classes reviewed: ADHD Ophthalmic antihistamines
FASENRA (benralizumab)
FASENRA (benralizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
End Stage COPD Guidance Document
End Stage COPD Guidance Document Suggested Guidelines for the Determination of Hospice Eligibility A patient with severe chronic pulmonary disease that meets the following criteria may be eligible for
STRIVERDI RESPIMAT (olodaterol hcl) aerosol
STRIVERDI RESPIMAT (olodaterol hcl) aerosol Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
Triptan Quantity Limit
*- Florida Healthy Kids Triptan Quantity Limit Override(s) Quantity Limit Approval Duration 1 year Oral Tablets Axert (almotriptan) tablets Relpax (eletriptan) tablets 6 tablets (6.25 mg) 12 tablets (12.5
Oregon Health Plan prescription benefit updates
Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
Correct Use of Inhaler Devices
PL Detail-Document #300206 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER February 2014 Correct Use of
MEDICAID QUANTITY LIMIT DRUG LIST
MEDICAID QUANTITY LIMIT DRUG LIST PH51-R-02162018 Brand Name Generic Name Dosage Form Tier Quantity Limit Details Cambia Diclofenac Potassium PACK Tier 2 QL: 9 per 30 days Fentanyl (12 Mcg/Hr, 25 Mcg/
Michigan Department of Community Health Quantity Limitations
Abstral (fentanyl) sl tab all strength Acetaminophen Actonel Actonel 35mg Adderall XR 5mg, 10mg, 15mg 240 per 34 days 3 gm/day 2 every 28 days 4 every 28 days Advair Diskus. No more than 180 every 30 days
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. Uniform Formulary Review Process Under 10 U.S.C. 1074g, as implemented by 32
ABILIFY ABILIFY DISCMELT ACTONEL ACTOPLUS MET ACTOPLUS MET XR ACTOS ADCIRCA ADVAIR DISKUS ADVAIR HFA
Quantity Limits Paramount Medicare Formulary 2012 Formulary ID 12112, Version 22. CMS Approved 10-23-2012. ABILIFY Abilify TABS ABILIFY DISCMELT Abilify Discmelt ACTONEL Actonel TABS 150MG Actonel TABS
MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
CINQAIR (reslizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
Foundations of Pharmacology
Pharmacologic Management of Asthma Objectives: 1. Review the physiological basis for asthma therapy 2. Discuss the differences between SABA and LABA 3. Discuss the role of inhaled and oral systemic corticosteroids
The Medical Letter. on Drugs and Therapeutics. Drug Some Formulations OTC/Rx Usual Dosage Comments Class Comments Cost 1
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
Cost Effectiveness Recommendations For Kentucky Retirement Systems MTM Plan 2011
Medication Tier 2 options Tier 1 options Nexium- Tier 3 Aciphex Lansoprazole Omeprazole Pantoprazole Crestor- Tier 3 Lipitor Simvastatin Vytorin- Tier 3 Atacand- Tier 3 Avapro Benicar Cozaar Micardis Tevetan
COPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator
Medicine. No one ever showed me how to use this. Wendy Happel; RRT, Educator Krystal Fedoris; RRT-NPS, BA, Educator 1 Taking prescriptions correctly Taking prescriptions can be a challenge Busy schedules
Three-Tier Prescription Drug Benefits Rider
Three-Tier Prescription Drug Benefits Rider Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions
CHICAGO REGIONAL COUNCIL OF CARPENTERS WELFARE FUND RETIREE PRESCRIPTION DRUG BENEFITS October 2013
CHICAGO REGIONAL COUNCIL OF CARPENTERS WELFARE FUND RETIREE PRESCRIPTION DRUG BENEFITS October 2013 How to Use the Prescription Drug Program The Chicago Regional Council of Carpenters Welfare Fund has
reslizumab (Cinqair )
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
Prescription Drug Benefit Rider
Prescription Drug Benefit Rider Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your
Inhaled Corticosteroids Drug Class Prior Authorization Protocol
Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review
Health Net Health Plan of Oregon, Inc. Oregon Drugs with a quantity limit Effective January 1, 2015 (Published December 15, 2014)
Health Net Health Plan of Oregon, Inc. Oregon Drugs with a quantity limit Effective January 1, 2015 (Published December 15, 2014) Abstral SL Actonel 35mg Limited to 4 s per month. Actonel 5,30mg adapalene
Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
Clinical Policy: Roflumilast (Daliresp) Reference Number: CP.PMN.46 Effective Date: Last Review Date: 08.18
Clinical Policy: (Daliresp) Reference Number: CP.PMN.46 Effective Date: 11.01.11 Last Review Date: 08.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important
Michigan Department of Community Health Co-pay and Quantity Limitations
Michigan Department of Community Health Co-pay and Quantity Limitations Benefit Plan Co-pay Information Group ID Coverage Co-pay INCARCE Incarcerated Medicaid No coverage No coverage patients SHPDUAL CSHCSCAID
Inhaled Corticosteroids Drug Class Prior Authorization Protocol
Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review
Three-Tier Prescription Drug Benefit Rider A
Three-Tier Prescription Drug Benefit Rider A Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions
Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma
Allergies and Asthma Presented By: Dr. Fadwa Gillanders, Pharm.D Clinical Pharmacy Specialist May 2013 Objectives Understand the relationship between asthma and allergic rhinitis Understand what is going
Pharmacy Policy Bulletin
Pharmacy Policy Bulletin Title: Policy #: Age Edits Rx.01.2 Application of pharmacy policy is determined by benefits and contracts. Benefits may vary based on product line, group, or contract. Some medications
Michigan Department of Health & Human Services Quantity Limitations
Abstral (fentanyl) sl tab all strength Acetaminophen Actonel Actonel 35mg Adderall XR 5mg, 10mg, 15mg Advair Diskus Advair HFA Aero Chambers and Spacers Aerobid Aerobid M Albuterol HFA 90mcg Akynzeo Aldara
Impact of a Comprehensive COPD Therapeutic Interchange Program on 30-Day Readmission Rates in Hospitalized Patients
Impact of a Comprehensive COPD Therapeutic Interchange Program on 30-Day Readmission Rates in Hospitalized Patients Maren A. McGurran, PharmD, BCPS; Lisa M. Richter, PharmD, BCPS, BCCCP; Nathan D. Leedahl,
Pharmacy Medical Necessity Guidelines: Migraine Medications
Pharmacy Medical Necessity Guidelines: Effective: September 18, 2017 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED)
Oral Agents. Fml Limits. Available Strengths NF NF
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Allergy Medications LAST REVIEW: 9/12/2017 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 9/16, 5/15, 9/14
ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component
ANTINEOPLASTIC DRUGS CHAPTER 21 Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component Tx of malignancies Antineoplastic drugs: methotrexate
CAMPER APPLICATION PACKET
CAMPER APPLICATION PACKET Monday- Friday June 12-16, 2017 Rockport, Texas DEADLINE FOR SUBMITTING ALL FORMS: THE IMPORTANCE OF COMPLETING ALL CAMP FORMS Although it may seem like a lot of paperwork, the
MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS
MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS The November 22, 2016 Mid-Year Financial Report referred to changes to drug coverage under the Saskatchewan Drug Plan. What
Asthma/COPD Update with Inhaler Workshop
Asthma/COPD Update with Inhaler Workshop October 8, 2017 Nathan Samsa, DO, Pharm D, RPh, FACOI None Disclosures Agenda Asthma Updates COPD Updates Inhaler Workshop Medication Acronyms SABA: Short acting
COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes
COPD Medications Coverage Summary Drug Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes Ventolin MDI + generics Yes Yes Ventolin Diskus NO NO Yukon Pharmacare/Chronic Disease Program
Objectives. Speaker has no relationship to disclose. Sneezes, Wheezes, and Respiratory Diseases: An update on Asthma, Allergic Rhinitis,
Sneezes, Wheezes, and Respiratory Diseases: An update on Asthma, Allergic Rhinitis, and COPD Amelie Hollier, DNP, FNP-BC, FAANP Advanced Practice Education Associates Objectives Evaluation of medications,
MDI Bonanza. Dwayne Griffin, DO
MDI Bonanza Dwayne Griffin, DO Bonanza 3. A MDI costing $200 - $500 per month SISYPHUS MDI Griffin Mountain Evolution of Deliver Systems for COPD in the US 2003 2009 2011 2013 2004 2012 2014 Prescribing
Women Beware-The Threat of COPD
Page 1 Speaker: Catherine Cooke attained her Bachelor in Pharmacy from the University of Iowa and then went on to receive her Pharm.D. from the Medical University of South Carolina. Subsequently, she completed
Common Inhaled Asthma Medications Dose Comparison and Tips for Use
Detail-Document #210303 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER March 2005 ~ Volume 21 ~ Number 210303 Common Inhaled Asthma Medications
Drug Effectiveness Review Project Summary Report
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
Asthma. Definition. Symptoms
Asthma Definition Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some
QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol)
Carelirst. +.V Family of health care plans DRUG CLASS COMBINATIONS QUANTITY LIMIT CRITERIA LONG ACTING BETA2-ADRENERGIC AGONIST, ORAL INHALATION BRAND NAME (generic) LONG-ACTING BETA2-ADRENERGIC AGONISTS:
Anthem Prescription Management s Clinical Connections Program
Anthem Prescription Management s Clinical Connections Program Anthem Prescription is committed to helping you manage your health care benefits. Prior Authorization, Quantity Limits and are edits recommended
Inhaled Corticosteroid Dose Comparison in Asthma
This Clinical Resource gives subscribers additional insight related to the Recommendations published in April 2017 ~ Resource #330402 Inhaled Corticosteroid Dose Comparison in Asthma The chart below provides
TABLE OF CONTENTS (Click on a link below to view the section.)
Follow the links below to access the complete formularies for Plans: Health Plan Acne Allergy Allergic Anaphylactic Reaction Allergic Conjunctivitis Allergic Rhinitis Asthma Atopic Dermatitis Behavioral
Women Beware The Threat of COPD
Page 1 Women Beware The Threat of COPD Catherine E. Cooke, PharmD, BCPS, PAHM President, PosiHealth, Inc. & Clinical Associate Professor, University of Maryland School of Pharmacy Supported by an education
Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir
Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires
Michigan Department of Health & Human Services Quantity Limitations
Quantity s Abstral (fentanyl) sl tab all strength acetaminophen Actonel Actonel 35mg Adderall XR 5mg, 10mg, 15mg Advair Diskus Advair HFA Aero Chambers and Spacers Aerobid Aerobid M albuterol HFA 90mcg
II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical
Table 3.1. Classification of COPD Severity Stage Pulmonary Function Test Findings Symptoms I: Mild Mild airflow limitations +/ Chronic cough and sputum production; patient unaware of abnormal FEV 1 80%
Improving Outcomes in COPD
Neil MacIntyre MD Duke University Durham NC Current treatment guidelines f COPD focus Barriers to providing optimal treatment Diagnosis of COPD EXPOSURE TO RISK FACTORS AND/ OR SYMPTOMS sputum cough dyspnea
Triage Information: 1. Duration of HPSJ Membership 2. Age 3. Fill history of Seasonal Allergy Medications
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Seasonal Allergy Medications LAST REVIEW: 5/28/2015 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 5/15, 9/14
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Fasenra) Reference Number: CP.PHAR.## Effective Date: 01.16.18 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy
Health New England (HNE) is making some changes to your Plan, most of which become effective July 1, 2015.
April 17, 2015 FULLY FUNDED PLANS ONLY RE: Semi-Annual Notice of Changes Dear HNE Member: Health New England (HNE) is making some changes to your Plan, most of which become effective July 1, 2015. I have
Prescription Drugs with Dispensing Limits or Prior Authorization Requirements
Prescription Drugs with s or Requirements MHBP provides benefits for most covered prescription drugs for up to a 30-day supply when purchased at a retail pharmacy, and receive up to a 90 day supply for
Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018
Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management Colleen Sakon, PharmD BCPS September 27, 2018 Disclosures I have no actual or potential conflicts of interest 2 Objectives Summarize
TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018
TEST Network Health Insurance Corporation NetworkCares Step Therapy Last Updated 11/2018 ANTICONVULSANT THERAPY Aptiom Banzel Briviact Celontin Dilantin 30 Mg Capsule Equetro Fycompa 0.5 Mg/ml Oral Susp
SmithRx Standard Formulary Step Therapy List
SmithRx Standard Formulary Step Therapy List Revised: January 27, 2017 The following medications require prior use of at least one other medication for coverage. Please note that any plan-specific customizations
benralizumab (Fasenra )
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
2014 Step Therapy Criteria (List of Step Therapy Criteria)
Criteria Last Updated: November 1, 2014 2014 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP MEDICARE DUALCHOICE (HMO SNP) REQUIRES YOU TO FIRST TRY CERTAIN DRUGS TO TREAT
Provider Respiratory Inservice
Provider Respiratory Inservice 2 Welcome Opening Remarks We will cover: Definition of Asthma & COPD Evidence based guidelines for diagnosis, evaluation, and management of asthma Evidence based guidelines
PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 11/16/17 SECTION: DRUGS LAST REVIEW DATE: 11/16/17 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
LEVALBUTEROL HFA (levalbuterol tartrate) inhalation aerosol Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit
Objec9ves. Drug Classes with Indications to Treat AR. Allergic Rhinitis. Allergic Rhinitis. Action Statements
Sneezes, Wheezes, and espiratory Diseases: An update on Asthma, Allergic hini5s, and COPD Amelie Hollier, DNP, FNP-BC, FAANP Advanced Practice Education Associates Objec9ves Evalua9on of the latest allergic
II. UF CLASS REVIEWS NASAL ALLERGY DRUGS
DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code
Lower your costs. Save money with preferred generic and preferred brand-name drugs 2018 Aetna Rx Step Program Medicine List
Call out bold Call out light Contact information, call X-XXX-XXX-XXXX or visit www.aetna.com Call to action small copy (especially related to mobile apps). Hendani adionse rferum faceatis incte voluptassi
BB&T Drug Quantity Program List
BB&T Drug Quantity Program List To help make the use of prescription drugs safer and more affordable, our plan is now using a Drug Quantity Management program. That is, for certain medications, you can